Bioventus Inc. (BVS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $455.11M | -16.1% |
| 2024 | $542.35M | -8.0% |
| 2023 | $589.79M | -38.6% |
| 2022 | $960.43M | +55.4% |
| 2021 | $618.21M | +76.5% |
| 2020 | $350.31M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $455.11M | -16.1% |
| 2024 | $542.35M | -8.0% |
| 2023 | $589.79M | -38.6% |
| 2022 | $960.43M | +55.4% |
| 2021 | $618.21M | +76.5% |
| 2020 | $350.31M | — |